|
Index of reports
> Disability (54)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakote (Divalproex) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 54 Next >>
Possible Depakote side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Bedridden, Emphysema, Off Label Use, Lung Disorder, Amnesia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Potassium Chloride (KV / 24)
Dosage: 8 meq, qd
Indication: Blood Potassium
Generlac
Dosage: 30 mg, prn
Indication: Crohn's Disease
Atenolol
Dosage: 25 mg, qd
Administration route: Oral
Indication: Hypertension
Tylenol
Dosage: unk unk, qd
Indication: Migraine
Aspirin
Dosage: 81 mg, prn
Indication: Chest Pain
Lantus
Dosage: 80 units in the moring and 90 units at night
Indication: Diabetes Mellitus
Lantus
Dosage: unk
Atropine Sulfate
Dosage: 2.5 mg, qid
Administration route: Oral
Indication: Crohn's Disease
Depakote
Dosage: 500 mg, bid
Administration route: Oral
Indication: Convulsion
Ativan
Dosage: 1 mg, tid
Administration route: Oral
Indication: Nervousness
Zocor
Dosage: 40 mg, qd
Administration route: Oral
Zantac
Dosage: 30 mg, tid
Administration route: Oral
Indication: Gastrooesophageal Reflux Disease
Potassium Chloride
Remeron
Dosage: 30 mg, qd
Administration route: Oral
Indication: Insomnia
Dilantin
Dosage: 300 mg, bid
Administration route: Oral
Indication: Convulsion
Imdur
Dosage: 30 mg, tid
Indication: Cardiac Disorder
Methocarbamol
Indication: Neuropathy Peripheral
Norvasc
Administration route: Oral
Indication: Palpitations
Humulin R
Dosage: 24 units
Indication: Diabetes Mellitus
Furosemide
Dosage: 40 mg, bid
Administration route: Oral
Indication: Diuretic Therapy
Methocarbamol
Dosage: 750 mg, prn
Administration route: Oral
Indication: Muscle Spasms
Nitrostat
Dosage: 0.4 mg, prn
Indication: Chest Pain
Possible Depakote side effects in
Reported by a consumer/non-health professional from France on 2012-08-23
Patient:
Reactions: Portal Hypertension, Fatigue, Hypothermia, Anaemia, Epistaxis, Hepatic Cirrhosis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Risperidone
Indication: Bipolar Disorder
End date: 2011-01-01
Mediator
Dosage: unk
Indication: Diabetes Mellitus
Start date: 2006-01-01
End date: 2006-01-01
Metformin Hydrochloride
Repaglinide
Dosage: unk
Indication: Diabetes Mellitus
Start date: 2011-05-01
End date: 2011-01-01
Depakote
Dosage: 500 mg, unk
Indication: Bipolar Disorder
End date: 2006-01-01
Diamicron
Dosage: 60 mg, unk
Indication: Diabetes Mellitus
End date: 2011-01-01
Glucophage
Dosage: unk
Glucophage
Administration route: Oral
Sitagliptin Phosphate
Dosage: unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2009-04-01
End date: 2011-01-01
Glucophage
Indication: Diabetes Mellitus
End date: 2011-01-01
Abilify
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Metformin Hydrochloride
Dosage: unk
Indication: Diabetes Mellitus
End date: 2011-05-01
Insulin
Dosage: unk
Start date: 2011-05-01
Possible Depakote side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22
Patient:
Reactions: Bedridden, Emphysema, Amnesia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Methocarbamol
Administration route: Oral
Furosemide
Administration route: Oral
Dilantin
Administration route: Oral
Potassium Chloride
Depakote
Administration route: Oral
Aspirin
Lomotil
Administration route: Oral
Humulin R
Lantus
Dosage: 80 iu, qam
Nitrostat
Ativan
Administration route: Oral
Zantac
Atenolol
Administration route: Oral
Lantus
Dosage: 90 df, qpm
Zocor
Administration route: Oral
Generlac
Norvasc
Administration route: Oral
Tylenol W / Codeine NO. 3
Remeron
Administration route: Oral
Isosorbide Mononitrate
Possible Depakote side effects in
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient:
Reactions: Bedridden, Emphysema, Chronic Obstructive Pulmonary Disease, Amnesia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Norvasc
Administration route: Oral
Dilantin
Dosage: 300 mg, bid
Administration route: Oral
Tylenol W / Codeine
Dosage: unk, qd
Lantus
Dosage: 80 iu, qam
Lantus
Dosage: 90 iu, qpm
Lomotil
Dosage: 2.5 mg, qid
Administration route: Oral
Isosorbide Mononitrate
Dosage: 30 mg, tid
Potassium Chloride
Dosage: 8 meq, qd
Depakote
Dosage: 500 mg, bid
Administration route: Oral
Methocarbamol
Dosage: 750 mg, prn
Administration route: Oral
Lactulose
Dosage: 30 mg, prn
Atenolol
Dosage: 25 mg, qd
Administration route: Oral
Nitrostat
Dosage: 0.4 mg, prn
Aspirin
Dosage: 81 mg, prn
Ativan
Dosage: 1 mg, tid
Administration route: Oral
Zocor
Dosage: 40 mg, qd
Administration route: Oral
Furosemide
Dosage: 40 mg, bid
Administration route: Oral
Humulin R
Dosage: 24 iu, tid
Zantac
Dosage: 300 mg, tid
Remeron
Dosage: 30 mg, qd
Administration route: Oral
Possible Depakote side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient:
Reactions: Bedridden, Emphysema, Chronic Obstructive Pulmonary Disease, Amnesia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Zocor
Dosage: 40 mg, unk
Administration route: Oral
Humulin R
Dosage: 24 iu, tid
Depakote
Dosage: 500 mg, bid
Administration route: Oral
Ativan
Dosage: 1 mg, tid
Administration route: Oral
Zantac
Dosage: 300 mg, tid
Dilantin
Dosage: 300 mg, bid
Administration route: Oral
Remeron
Dosage: 30 mg, unk
Administration route: Oral
Isosorbide Mononitrate
Dosage: 30 mg, tid
Lomotil
Dosage: 2.5 (4 in d) mg,
Administration route: Oral
Lantus
Dosage: 80 iu, unk
Furosemide
Dosage: 40 mg, bid
Administration route: Oral
Aspirin
Dosage: 81 mg, prn
Nitrostat
Dosage: 0.4 mg, prn
Atenolol
Dosage: 25 mg, qd
Administration route: Oral
Tylenol (Caplet)
Dosage: 1 df, qd
Lantus
Dosage: 90 iu, unk
Potassium Chloride
Dosage: 8 meq, qd
Norvasc
Dosage: unk
Administration route: Oral
Lactulose
Dosage: 30 mg, prn
Methocarbamol
Dosage: 750 mg, prn
Administration route: Oral
Possible Depakote side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31
Patient:
Reactions: Product Quality Issue, Bedridden, Emphysema, Lung Disorder, Amnesia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Atenolol
Dosage: 25 mg, qd
Administration route: Oral
Nitrostat
Dosage: 0.4 mg, prn
Lantus
Dosage: 170 df, qd
Tylenol W / Codeine NO. 3
Dosage: unk, qd
Methocarbamol
Dosage: 750 mg, prn
Administration route: Oral
Dilantin
Dosage: 300 mg, bid
Administration route: Oral
Zocor
Dosage: 40 mg, qd
Administration route: Oral
Norvasc
Administration route: Oral
Depakote
Dosage: 500 mg, bid
Administration route: Oral
Humulin R
Dosage: 24 df, tid
Ativan
Dosage: 1 mg, tid
Administration route: Oral
Potassium Chloride
Dosage: 8 meq, unk
Aspirin
Dosage: 81 mg, prn
Administration route: Oral
Lomotil
Dosage: 2.5 mg, qid
Administration route: Oral
Isosorbide Mononitrate
Dosage: 30 mg, tid
Administration route: Oral
Zantac
Dosage: 300 mg, tid
Furosemide
Dosage: 40 mg, bid
Administration route: Oral
Lactulose
Dosage: 30 mg, prn
Remeron
Dosage: 30 mg, qd
Administration route: Oral
Possible Depakote side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31
Patient:
Reactions: Emphysema, Bedridden, Amnesia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Lomotil
Dosage: 2.5 mg, qid
Administration route: Oral
Indication: Crohn's Disease
Atenolol
Dosage: 25 mg, qd
Administration route: Oral
Indication: Hypertension
Tylenol W / Codeine NO. 3
Dosage: unk unk, qd
Indication: Migraine
Nitrostat
Dosage: 0.4 mg, prn
Indication: Chest Pain
Generlac
Dosage: 30 mg, prn
Indication: Crohn's Disease
Furosemide
Dosage: 40 mg, bid
Administration route: Oral
Potassium Chloride
Dosage: 8 meq, qd
Indication: Mineral Supplementation
Zantac
Dosage: 300 mg, tid
Indication: Gastrooesophageal Reflux Disease
Aspirin
Dosage: 81 mg, prn
Indication: Chest Pain
Remeron
Dosage: 30 mg, qd
Administration route: Oral
Indication: Insomnia
Zocor
Dosage: 40 mg, qd
Administration route: Oral
Indication: Blood Cholesterol Increased
Lantus
Dosage: 80 units in morning, 90 units at night
Indication: Diabetes Mellitus
Humulin R
Dosage: 24 iu, tid
Indication: Diabetes Mellitus
Methocarbamol
Dosage: 750 mg, prn
Administration route: Oral
Indication: Muscle Spasms
Methocarbamol
Dosage: unk
Indication: Neuropathy Peripheral
Dilantin
Dosage: 300 mg, bid
Administration route: Oral
Indication: Convulsion
Isosorbide Mononitrate
Dosage: 30 mg, tid
Indication: Cardiac Disorder
Depakote
Dosage: 500 mg, bid
Administration route: Oral
Indication: Convulsion
Ativan
Dosage: 1 mg, tid
Administration route: Oral
Indication: Nervousness
Norvasc
Administration route: Oral
Indication: Cardiac Disorder
Norvasc
Indication: Lung Disorder
Possible Depakote side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31
Patient:
Reactions: Bedridden, Emphysema, Chronic Obstructive Pulmonary Disease, Amnesia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Zocor
Administration route: Oral
Zantac
Methocarbamol
Administration route: Oral
Isosorbide Mononitrate
Nitrostat
Dilantin
Administration route: Oral
Remeron
Administration route: Oral
Potassium Chloride
Depakote
Administration route: Oral
Lantus
Dosage: 90 df, qpm
Atenolol
Administration route: Oral
Ativan
Administration route: Oral
Furosemide
Administration route: Oral
Norvasc
Administration route: Oral
Generlac
Tylenol W / Codeine NO. 3
Lomotil
Administration route: Oral
Humulin R
Aspirin
Lantus
Dosage: 80 iu, qam
Possible Depakote side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: 51 year old female
Reactions: Fatigue, Hypothermia, Anaemia, Hepatic Cirrhosis, Epistaxis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Risperidone
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Glucophage
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Repaglinide
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Metformin HCL
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Abilify
Dosage: jun2009,15mg/d
Indication: Bipolar Disorder
Start date: 2009-01-01
End date: 2011-01-01
Metformin Hydrochloride
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Depakote
Dosage: depakote 500 mg
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Sitagliptin Phosphate
Dosage: xelevia 100 mg xelevia 1000 mg
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Mediator
Indication: Diabetes Mellitus
Start date: 2006-01-01
End date: 2009-01-01
Diamicron
Dosage: diamicron 60mg
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Glucophage
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Other drugs received by patient: Delursan
Possible Depakote side effects in 51 year old female
Reported by a consumer/non-health professional from France on 2012-07-18
Patient: 51 year old female
Reactions: Fatigue, Hypothermia, Anaemia, Hepatic Cirrhosis, Epistaxis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Risperidone
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Repaglinide
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Diamicron
Dosage: diamicron 60mg
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Glucophage
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Abilify
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Depakote
Dosage: depakote 500 mg
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Glucophage
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Metformin HCL
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Sitagliptin Phosphate
Dosage: xelevia 100 mg xelevia 1000 mg
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Metformin Hydrochloride
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Mediator
Indication: Diabetes Mellitus
Start date: 2006-01-01
End date: 2009-01-01
Other drugs received by patient: Delursan
Possible Depakote side effects in
Reported by a consumer/non-health professional from United States on 2012-07-02
Patient:
Reactions: Anxiety, Cardiac Flutter, Atrial Fibrillation
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Depakote
Possible Depakote side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-22
Patient: 59 year old male
Reactions: Hepatic Enzyme Increased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Depakote
Other drugs received by patient: Perphenazine; Cephalexin; Diphenhydramine 10 MG; Benztropine Mesylate; Protein; Lorazepam; Haloperidol; Albumin (Human); Bilirubin; Divalproex Sodium; Ziprasidone HCL
Possible Depakote side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-12
Patient: 51 year old female
Reactions: Fatigue, Hypothermia, Anaemia, Epistaxis, Hepatic Cirrhosis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Abilify
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Repaglinide
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Glucophage
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Metformin HCL
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Metformin Hydrochloride
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Risperidone
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Depakote
Dosage: depakote 500 mg
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Glucophage
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Diamicron
Dosage: diamicron 60mg
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Mediator
Indication: Diabetes Mellitus
Start date: 2006-01-01
End date: 2009-01-01
Sitagliptin Phosphate
Dosage: xelevia 100 mg xelevia 1000 mg
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Possible Depakote side effects in 55 year old female
Reported by a consumer/non-health professional from United States on 2012-06-07
Patient: 55 year old female, weighing 77.1 kg (169.6 pounds)
Reactions: Agitation, Dyskinesia, Deafness, Amnesia, Tremor, Anxiety, Dyspepsia, Grip Strength Decreased, Vision Blurred, Eye Movement Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Depakote
Possible Depakote side effects in 58 year old male
Reported by a consumer/non-health professional from United States on 2012-05-22
Patient: 58 year old male, weighing 65.8 kg (144.7 pounds)
Reactions: Burning Sensation, Mania
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Clopazim
Dosage: 200mg morning
Indication: Bipolar I Disorder
Depakote
Dosage: 200 m 300 e morning evening
Other drugs received by patient: Abilify; Colozeral
Possible Depakote side effects in 51 year old female
Reported by a consumer/non-health professional from Germany on 2012-05-11
Patient: 51 year old female
Reactions: Fatigue, Hypothermia, Anaemia, Hepatic Cirrhosis, Epistaxis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Repaglinide
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Abilify
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Metformin HCL
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Glucophage
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Depakote
Dosage: depakote 500 mg
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Diamicron
Dosage: diamicron 60mg
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Mediator
Indication: Diabetes Mellitus
Start date: 2006-01-01
End date: 2009-01-01
Glucophage
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Sitagliptin Phosphate
Dosage: xelevia 100 mg xelevia 1000 mg
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Metformin Hydrochloride
Indication: Diabetes Mellitus
Start date: 2002-01-01
End date: 2011-01-01
Risperidone
Indication: Bipolar Disorder
Start date: 1995-01-01
End date: 2011-01-01
Possible Depakote side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-26
Patient: male, weighing 63.5 kg (139.7 pounds)
Reactions: Rash Erythematous, Breast Mass, Gait Disturbance, Bone Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Zyprexa
Dosage: 10 mg ? 1x/day p.o. 6 or 8 of '09 til 11-11
Administration route: Oral
Indication: Anger
Depakote
Dosage: 500 mg ? 1 x / day p.o. 6 or 8 of '09 til 11-'11
Other drugs received by patient: Fish OIL; Vitamin C; Multi-Vitamin
Possible Depakote side effects in 48 year old female
Reported by a individual with unspecified qualification from United States on 2012-04-13
Patient: 48 year old female, weighing 90.0 kg (198.0 pounds)
Reactions: Bedridden, Emphysema, Product Quality Issue, Amnesia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Lomotil
Dosage: 10 mg (2.5 mg,4 in 1 d),oral
Administration route: Oral
Indication: Crohn's Disease
Potassium Chloride
Dosage: (8 milliequivalents-
Indication: Blood Potassium Normal
Methocarbamol
Dosage: (750 mg,as required),oral
Administration route: Oral
Indication: Muscle Spasms
Aspirin
Dosage: (81 mg,as required)
Indication: Chest Pain
Furosemide
Dosage: 80 mg (40 mg,2 in 1 d),oral
Administration route: Oral
Indication: Diuretic Therapy
Isosorbide Mononitrate
Dosage: 90 mg (30 mg,3 in 1 d)
Indication: Cardiac Disorder
Remeron
Dosage: (30 mg,1 d),oral
Administration route: Oral
Indication: Insomnia
Atenolol
Dosage: (25 mg,1 d),oral
Administration route: Oral
Indication: Hypertension
Humulin R
Dosage: 72 iu (24 iu,3 in 1 d)
Indication: Diabetes Mellitus
Lantus
Dosage: (170, 80 units morning and 90 units night)
Indication: Diabetes Mellitus
Ativan
Dosage: 3 mg (1 mg,3 in 1 d),oral
Administration route: Oral
Indication: Anxiety
Depakote
Dosage: 1000 mg (500 mg,2 in 1 d),oral
Administration route: Oral
Indication: Convulsion
Norvasc
Dosage: oral
Administration route: Oral
Indication: Cardiac Disorder
Dilantin
Dosage: 600 mg (300 mg,2 in 1 d),oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Tylenol W / Codeine NO. 3
Dosage: (1 d)
Indication: Migraine
Simvastatin
Dosage: (40 mg,1 d),oral
Administration route: Oral
Indication: Blood Cholesterol Increased
Nitrostat
Dosage: (0.4 mg,as required)
Indication: Chest Pain
Lactulose
Dosage: (30 mg,as required)
Indication: Crohn's Disease
Zantac
Dosage: 900 mg (300 mg,3 in 1 d)
Indication: Gastrooesophageal Reflux Disease
Possible Depakote side effects in 48 year old female
Reported by a individual with unspecified qualification from United States on 2012-04-11
Patient: 48 year old female, weighing 90.0 kg (198.0 pounds)
Reactions: Bedridden, Emphysema, Chronic Obstructive Pulmonary Disease, Amnesia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Simvastatin
Dosage: (40 mg,1 d),oral
Administration route: Oral
Indication: Blood Cholesterol Increased
Aspirin
Dosage: (81 mg,as required)
Indication: Chest Pain
Depakote
Dosage: 1000 mg (500 mg,2 in 1 d),oral
Administration route: Oral
Indication: Convulsion
Humulin R
Dosage: 72 iu (24 iu,3 in 1 d)
Indication: Diabetes Mellitus
Dilantin
Dosage: 600 mg (300 mg,2 in 1 d),oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Isosorbide Mononitrate
Dosage: 90 mg (30 mg,3 in 1 d)
Indication: Cardiac Disorder
Zantac
Dosage: 900 mg (300 mg,3 in 1 d),
Remeron
Dosage: (30 mg,1 d),oral
Administration route: Oral
Methocarbamol
Dosage: (750 mg,as required),oral
Administration route: Oral
Indication: Blood Potassium Abnormal
Methocarbamol
Dosage: (750 mg,as required),oral
Administration route: Oral
Indication: Muscle Spasms
Atenolol
Dosage: (25 mg,1 d),oral
Administration route: Oral
Indication: Hypertension
Lactulose
Dosage: (30 mg,as required)
Indication: Crohn's Disease
Lomotil
Dosage: 10 mg (2.5 mg,4 in 1 d),oral
Administration route: Oral
Indication: Crohn's Disease
Nitrostat
Dosage: (0.4 mg,as required)
Indication: Chest Pain
Potassium Chloride
Dosage: (8 milliequivalents,1 d)
Indication: Blood Pressure Abnormal
Norvasc
Dosage: oral
Administration route: Oral
Indication: Cardiac Disorder
Norvasc
Dosage: oral
Administration route: Oral
Indication: Lung Disorder
Furosemide
Dosage: 80 mg (40 mg,2 in 1 d),oral
Administration route: Oral
Indication: Diuretic Therapy
Tylenol W / Codeine NO. 3
Dosage: (1 d)
Indication: Migraine
Lantus
Dosage: (170 , 80 units morning and 90 units night)
Indication: Diabetes Mellitus
Ativan
Dosage: 3 mg (1 mg,3 in 1 d),oral
Administration route: Oral
Possible Depakote side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-11
Patient: female, weighing 53.5 kg (117.7 pounds)
Reactions: Self Injurious Behaviour
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Depakote
Possible Depakote side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-09
Patient: female, weighing 53.5 kg (117.7 pounds)
Reactions: Intentional Self-Injury
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Depakote
Possible Depakote side effects in 48 year old female
Reported by a consumer/non-health professional from United States on 2012-04-06
Patient: 48 year old female, weighing 90.0 kg (198.0 pounds)
Reactions: Bedridden, Emphysema, Amnesia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Lomotil
Administration route: Oral
Indication: Crohn's Disease
Ativan
Administration route: Oral
Indication: Anxiety
Methocarbamol
Administration route: Oral
Indication: Neuropathy Peripheral
Furosemide
Administration route: Oral
Indication: Diuretic Therapy
Atenolol
Administration route: Oral
Indication: Hypertension
Zantac
Indication: Gastrooesophageal Reflux Disease
Humulin R
Indication: Diabetes Mellitus
Simvastatin
Administration route: Oral
Indication: Blood Cholesterol Increased
Lantus
Dosage: 80 units in the morning and 90 units in the night
Indication: Diabetes Mellitus
Norvasc
Administration route: Oral
Indication: Cardiac Disorder
Tylenol W / Codeine NO. 3
Indication: Migraine
Aspirin
Indication: Chest Pain
Nitrostat
Indication: Chest Pain
Methocarbamol
Administration route: Oral
Indication: Muscle Spasms
Isosorbide Mononitrate
Indication: Cardiac Disorder
Potassium Chloride
Indication: Blood Potassium Abnormal
Depakote
Administration route: Oral
Indication: Convulsion
Generlac
Indication: Crohn's Disease
Remeron
Administration route: Oral
Indication: Insomnia
Norvasc
Administration route: Oral
Indication: Lung Disorder
Dilantin
Administration route: Oral
Indication: Convulsion
AN Unknown Medication
Indication: Depression
Possible Depakote side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-05
Patient: female, weighing 90.0 kg (198.0 pounds)
Reactions: Emphysema, Bedridden, Amnesia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Lomotil
Dosage: 2.5 mg, 4x/day
Administration route: Oral
Indication: Crohn's Disease
Dilantin
Dosage: 300 mg, 2x/day
Administration route: Oral
Lactulose
Dosage: 30 mg solution, as needed
Indication: Crohn's Disease
Simvastatin
Dosage: 40 mg, daily
Administration route: Oral
Indication: Blood Cholesterol Increased
Potassium Chloride
Dosage: 8 meq, daily
Indication: Blood Potassium Abnormal
Aspirin
Dosage: 81 mg, as needed
Indication: Chest Pain
Lantus
Dosage: 80units in the morning and 90 units at night
Indication: Diabetes Mellitus
Tylenol W / Codeine NO. 3
Dosage: unk daily
Indication: Migraine
Methocarbamol
Indication: Neuropathy Peripheral
Atenolol
Dosage: 25 mg, daily
Administration route: Oral
Indication: Hypertension
Furosemide
Dosage: 40 mg, 2x/day
Administration route: Oral
Indication: Diuretic Therapy
Isosorbide Mononitrate
Dosage: 30 mg, 3x/day
Indication: Cardiac Disorder
Depakote
Dosage: 500 mg, 2x/day
Administration route: Oral
Indication: Convulsion
Ativan
Dosage: 1 mg, 3x/day
Administration route: Oral
Indication: Anxiety
Methocarbamol
Dosage: 750 mg, as needed
Administration route: Oral
Indication: Muscle Spasms
Zantac
Dosage: 300 mg, 3x/day
Indication: Gastrooesophageal Reflux Disease
Remeron
Dosage: 30 mg, daily
Administration route: Oral
Indication: Insomnia
Norvasc
Dosage: unk
Administration route: Oral
Indication: Cardiac Disorder
Norvasc
Indication: Lung Disorder
Nitrostat
Dosage: 0.4 mg, as needed
Indication: Chest Pain
Humulin R
Dosage: 24 iu, 3x/day
Indication: Diabetes Mellitus
Possible Depakote side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-03
Patient: female, weighing 90.0 kg (198.0 pounds)
Reactions: Bedridden, Emphysema, Amnesia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Methocarbamol
Indication: Neuropathy Peripheral
Dilantin
Dosage: 300 mg, 2x/day
Administration route: Oral
Simvastatin
Dosage: 40 mg, daily
Administration route: Oral
Indication: Blood Cholesterol Increased
Lactulose
Dosage: 30 mg solution, as needed
Indication: Crohn's Disease
Depakote
Dosage: 500 mg, 2x/day
Administration route: Oral
Indication: Convulsion
Humulin R
Dosage: 24 iu, 3x/day
Indication: Diabetes Mellitus
Tylenol W / Codeine NO. 3
Dosage: unk daily
Indication: Migraine
Zantac
Dosage: 300 mg, 3x/day
Indication: Gastrooesophageal Reflux Disease
Isosorbide Dinitrate
Dosage: 30 mg, 3x/day
Indication: Cardiac Disorder
Potassium Chloride
Dosage: 8 meq, daily
Indication: Blood Potassium Abnormal
Furosemide
Dosage: 40 mg, 2x/day
Administration route: Oral
Indication: Diuretic Therapy
Remeron
Dosage: 30 mg, daily
Administration route: Oral
Indication: Insomnia
Atenolol
Dosage: 25 mg, daily
Administration route: Oral
Indication: Hypertension
Methocarbamol
Dosage: 750 mg, as needed
Administration route: Oral
Indication: Muscle Spasms
Aspirin
Dosage: 81 mg, as needed
Indication: Chest Pain
Lantus
Dosage: 80units in the morning and 90 units at night
Indication: Diabetes Mellitus
Ativan
Dosage: 1 mg, 3x/day
Administration route: Oral
Indication: Anxiety
Norvasc
Dosage: unk
Administration route: Oral
Indication: Cardiac Disorder
Norvasc
Indication: Lung Disorder
Nitrostat
Dosage: 0.4 mg, as needed
Indication: Chest Pain
Lomotil
Dosage: 2.5 mg, 4x/day
Administration route: Oral
Indication: Crohn's Disease
Possible Depakote side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-30
Patient: female, weighing 86.2 kg (189.6 pounds)
Reactions: Weight Increased, Syncope, Visual Acuity Reduced, Mental Retardation, Unevaluable Event, Unemployment
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Prolixin
Risperidol / Alonzopin
Dosage: 25mg- fried me shots
Start date: 1983-01-01
End date: 1984-01-01
Depakote
Haldol
Dosage: 25 mg - 100mg fried me shots
Start date: 1997-01-01
End date: 1998-01-01
Possible Depakote side effects in 48 year old female
Reported by a consumer/non-health professional from United States on 2012-03-29
Patient: 48 year old female, weighing 89.8 kg (197.6 pounds)
Reactions: Emphysema, Bedridden, Amnesia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Lantus
Dosage: 80units in the morning and 90 units at night
Indication: Diabetes Mellitus
Isosorbide Mononitrate
Indication: Cardiac Disorder
Norvasc
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Unspecified Medication
Indication: Depression
Dilantin
Administration route: Oral
Indication: Convulsion
Methocarbamol
Administration route: Oral
Indication: Neuropathy Peripheral
Potassium Chloride
Indication: Blood Potassium Abnormal
Aspirin
Indication: Chest Pain
Lomotil
Administration route: Oral
Indication: Crohn's Disease
Ativan
Administration route: Oral
Indication: Nervousness
Generlac
Indication: Crohn's Disease
Zantac
Indication: Gastrooesophageal Reflux Disease
Humulin R
Indication: Diabetes Mellitus
Tylenol W / Codeine
Dosage: daily
Indication: Migraine
Remeron
Administration route: Oral
Indication: Insomnia
Depakote
Administration route: Oral
Indication: Convulsion
Atenolol
Administration route: Oral
Indication: Hypertension
Furosemide
Administration route: Oral
Indication: Diuretic Therapy
Simvastatin
Administration route: Oral
Indication: Blood Cholesterol Increased
Methocarbamol
Administration route: Oral
Indication: Muscle Spasms
Nitrostat
Indication: Chest Pain
Possible Depakote side effects in 53 year old female
Reported by a consumer/non-health professional from United States on 2012-03-15
Patient: 53 year old female, weighing 59.0 kg (129.8 pounds)
Reactions: Mood Altered, Drug Ineffective, Impaired Work Ability, General Physical Health Deterioration, Blindness, Disability
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Keppra
Indication: Convulsion
Start date: 2011-10-06
End date: 2011-10-01
Gabapentin
Dosage: total daily dose: 2800 mg (1200 mg in noon and 800 mg in morning and at bedtime)
Indication: Convulsion
Start date: 2009-11-01
Gabapentin
Dosage: total daily dose: 2800 mg (1200 mg in noon and 800 mg in morning and at bedtime)
Start date: 1996-03-01
Depakote
Indication: Convulsion
Start date: 2011-10-27
End date: 2011-11-28
Valproic Acid
Indication: Convulsion
Other drugs received by patient: Savella; Soma
Possible Depakote side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-02
Patient: female, weighing 89.8 kg (197.6 pounds)
Reactions: Bedridden, Emphysema, Amnesia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Humulin R
Dosage: 24 iu tid
Indication: Diabetes Mellitus
Lomotil
Dosage: 2.5 mg qid oral
Administration route: Oral
Indication: Crohn's Disease
Atenolol
Dosage: 25 mg qd oral
Administration route: Oral
Indication: Hypertension
Nitrostat
Dosage: 0.4 mg, as needed
Indication: Chest Pain
Depakote
Dosage: 500 mg bid oral
Administration route: Oral
Indication: Convulsion
Simvastatin
Dosage: 40 mg qd oral
Administration route: Oral
Indication: Blood Cholesterol Increased
Acetaminophen W / Codeine NO. 3
Dosage: df, dail
Indication: Migraine
Methocarbamol
Dosage: 750 mg, as needed oral
Administration route: Oral
Indication: Muscle Spasms
Methocarbamol
Dosage: 750 mg, as needed oral
Administration route: Oral
Indication: Neuropathy Peripheral
Remeron
Dosage: 30 mg qd oral
Administration route: Oral
Indication: Insomnia
Ativan
Dosage: 1 mg tid oral
Administration route: Oral
Indication: Nervousness
Lantus
Dosage: 170 iu, 80 units in the morning and 90 units at night
Indication: Diabetes Mellitus
Antidepressants
Dosage: df
Indication: Depression
Isosorbide Mononitrate
Dosage: 30 mg tid
Indication: Cardiac Disorder
Generlac
Dosage: 30 mg, as needed
Indication: Crohn's Disease
Furosemide
Dosage: 40 mg bid oral
Administration route: Oral
Indication: Diuretic Therapy
Potassium Chloride
Dosage: 8 meq qd
Indication: Mineral Supplementation
Dilantin
Dosage: 300 mg bid oral
Administration route: Oral
Indication: Convulsion
Zantac
Dosage: 300 mg tid
Indication: Gastrooesophageal Reflux Disease
Aspirin
Dosage: 81 mg, as needed
Indication: Chest Pain
Norvasc
Dosage: df oral
Administration route: Oral
Indication: Cardiac Disorder
Possible Depakote side effects in 48 year old female
Reported by a consumer/non-health professional from United States on 2012-03-01
Patient: 48 year old female, weighing 90.0 kg (198.0 pounds)
Reactions: Bedridden, Emphysema, Amnesia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Lomotil
Administration route: Oral
Indication: Crohn's Disease
Potassium Chloride
Indication: Mineral Supplementation
Norvasc
Administration route: Oral
Indication: Lung Disorder
Generlac
Indication: Crohn's Disease
Atenolol
Administration route: Oral
Indication: Hypertension
Norvasc
Administration route: Oral
Indication: Cardiac Disorder
Remeron
Administration route: Oral
Indication: Insomnia
Lantus
Indication: Diabetes Mellitus
Zantac
Indication: Gastrooesophageal Reflux Disease
Humulin R
Indication: Diabetes Mellitus
Dilantin
Administration route: Oral
Indication: Convulsion
Tylenol W / Codeine NO. 3
Indication: Migraine
Methocarbamol
Administration route: Oral
Indication: Muscle Spasms
Nitrostat
Indication: Chest Pain
Aspirin
Indication: Chest Pain
Zocor
Administration route: Oral
Indication: Blood Cholesterol Increased
Furosemide
Administration route: Oral
Ativan
Administration route: Oral
Indication: Nervousness
Isosorbide Mononitrate
Indication: Cardiac Disorder
Depakote
Administration route: Oral
Indication: Convulsion
Methocarbamol
Administration route: Oral
Indication: Neuropathy Peripheral
Possible Depakote side effects in 50 year old female
Reported by a individual with unspecified qualification from United States on 2012-02-28
Patient: 50 year old female, weighing 58.5 kg (128.7 pounds)
Reactions: Drug Ineffective, Convulsion
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gabapentin
Dosage: (1200 mg, in noon), unknown
Indication: Product Used FOR Unknown Indication
Start date: 1996-03-01
Depakote
Dosage: 500 mg (250 mg, 2 in 1 d), unknown
Indication: Convulsion
Start date: 2011-10-27
End date: 2011-11-28
Kepra (Levetiracetam)
Dosage: 500 mg (250 mg, 2 in 1 d), unknown
Indication: Convulsion
Start date: 2011-10-06
End date: 2011-10-01
Valproic Acid
Indication: Convulsion
Other drugs received by patient: Savella (Milnaciproan Hydrochloride); Soma
Page 1 Next >>
|